📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Padagis

1.1 - Company Overview

Padagis Logo

Padagis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of generic Rx and OTC pharmaceuticals, including Brinzolamide Ophthalmic Suspension for ocular hypertension/open-angle glaucoma, Naloxone HCl Nasal Spray for opioid overdose, and extended topical prescription creams, ointments, suspensions, gels, foams, sprays, patches, nasal, and suppositories. Offers Paragraph IV specialty products and U.S. and Israel manufacturing and distribution across multiple dosage forms, including controlled substances.

Products and services

  • Manufacturing and Distribution: Operates multi-site facilities in the United States and Israel to produce and distribute diverse dosage forms, including controlled substances, supporting generic Rx and OTC portfolios
  • Extended Topicals: Delivers prescription-grade products—creams, ointments, suspensions, gels, foams, sprays, patches, nasal, and suppositories—covering varied dosage forms for Rx and OTC use
  • Paragraph IV Products: Constructs specialty-focused generic items that challenge branded pharmaceutical patents, with manufacturing centered on specialty pharmaceuticals

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Padagis

ValitaCell Logo

ValitaCell

HQ: Ireland Website
  • Description: Provider of biotechnology that enables faster, cheaper manufacturing of bio-therapeutic drugs, allowing users to select cells with greater regulatory confidence at the earliest stage of the drug development pathway and transforming the cell line development process.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ValitaCell company profile →
Pearl Pathways Logo

Pearl Pathways

HQ: United States Website
  • Description: Provider of life science product development and life-saving devices, diagnostics, and therapeutic products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pearl Pathways company profile →
WCCT Global Logo

WCCT Global

HQ: United States Website
  • Description: Provider of clinical trial services, research sites, and trial support for testing the safety and efficacy of new medications and medical devices, including participant recruitment, screening, and follow-up visits.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full WCCT Global company profile →
Qointa Logo

Qointa

HQ: Belgium Website
  • Description: Provider of a compliant, validated eHealth platform for device-agnostic patient monitoring and coaching, enabling direct randomization into adaptive clinical trials. Offers digital transformation and software validation solutions, quality and regulatory support (QMS and risk management), medical device software development, and electronic data integrity services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Qointa company profile →
Cellipont Logo

Cellipont

HQ: United States Website
  • Description: Provider of cell therapy CDMO services specializing in cell therapy development and small-to-large batch production.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cellipont company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Padagis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Padagis

2.2 - Growth funds investing in similar companies to Padagis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Padagis

4.2 - Public trading comparable groups for Padagis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Padagis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Padagis

What does Padagis do?

Padagis is a provider of generic Rx and OTC pharmaceuticals, including Brinzolamide Ophthalmic Suspension for ocular hypertension/open-angle glaucoma, Naloxone HCl Nasal Spray for opioid overdose, and extended topical prescription creams, ointments, suspensions, gels, foams, sprays, patches, nasal, and suppositories. Offers Paragraph IV specialty products and U.S. and Israel manufacturing and distribution across multiple dosage forms, including controlled substances.

Who are Padagis's competitors?

Padagis's competitors and similar companies include ValitaCell, Pearl Pathways, WCCT Global, Qointa, and Cellipont.

Where is Padagis headquartered?

Padagis is headquartered in United States.

How many employees does Padagis have?

Padagis has 1,000 employees 🔒.

When was Padagis founded?

Padagis was founded in 2010 🔒.

What sector and industry vertical is Padagis in?

Padagis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Padagis

Who are the top strategic acquirers in Padagis's sector and industry

Top strategic M&A buyers and acquirers in Padagis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Padagis?

Top strategic M&A buyers groups and sectors for Padagis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Padagis's sector and industry vertical

Which are the top PE firms investing in Padagis's sector and industry vertical?

Top PE firms investing in Padagis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Padagis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Padagis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Padagis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Padagis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Padagis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Padagis?

The key public trading comparables and valuation benchmarks for Padagis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Padagis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Padagis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Padagis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Padagis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Padagis's' sector and industry vertical?

Access recent funding rounds and capital raises in Padagis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Padagis

Launch login modal Launch register modal